Crismon, Lynn, Pharm.D.
Dean
James T. Doluisio Regents Chair
Behrens Inc. Centennial Professor
PHR 5.112G
512- 471-3718
crismonl@mail.utexas.edu

Dr. Crismon's current research and practice involve the development and evaluation of strategies to improve the pharmacotherapy, pharmacoeconomics, and health outcomes of individuals with mental disorders, particularly severe and persistent mental disorders seen in adults and children. Among his efforts, Dr. Crismon served as co-director of the Texas Medication Algorithm Project (TMAP) and director of the Children's Medication Algorithm Project (CMAP). These multi-institutional, multi-disciplinary, collaborative outcomes research projects combined the resources of the Texas Department of State Health Services, UT Southwestern Medical Center Department of Psychiatry, UT College of Pharmacy, and the Department of Psychiatry at the UT Health Sciences Center at San Antonio in order to address challenges identified for the delivery of care within public mental health systems. In TMAP, the consortium developed and evaluated algorithm driven disease management programs for the care of individuals with severe mental disorders, including bipolar disorder, major depressive disorder, and schizophrenia. In CMAP, algorithms were developed and evaluated for ADHD and depression. Dr. Crismon has also been actively involved in the development of guidelines for treatment of mental disorders in individuals with mental retardation, treatment of aggression in children, treatment of substance abuse disorders co-occurring with other mental disorders, diagnosis and treatment of osteoporosis in the mentally retarded, smoking cessation in minority populations, treatment of depression in multiple sclerosis, and evidenced based psychotherapy in depression.

Dr. Crismon's current major research studies include an evaluation of an intensive implementation of TIMA as a component of Texas Medicaid and the evaluation of web based interventions to change prescriber behavior and implement medication algorithms. Dr. Crismon is also actively involved in activities with the Texas Department of State Health Services to improve mental health care for foster children. Dissemination and implementation of evidence based practices as a component of usual care are important and challenging endeavors. Dr. Crismon has been actively involved in the dissemination and implementation of evidence based mental health care programs in a variety of health care organizations, including health care systems in California, Colorado, Illinois, Kentucky, New Mexico, New York, Nevada, Ohio, Pennsylvania, South Carolina, Texas, and Washington, D.C. Information regarding the Texas Medication Algorithm Project (TMAP); Children's Medication Algorithm Project (CMAP); and Texas Implementation of Medication Algorithms (TIMA) can be obtained at: http://www.dshs.state.tx.us/mentalhealth.shtm

Dr. Crismon and other faculty in the UT Center for Pharmacoeconomics Studies actively study the pharmacoeconomics and health outcomes of various mental disorders, including schizophrenia, depression, bipolar disorder, and children's psychiatric disorders. These studies provide valuable information regarding the outcomes and costs associated with pharmacotherapy for these disorders.

In collaboration with other faculty in the Divisions of Pharmacy Practice and Pharmacy Administration, Dr. Crismon offers advanced research and clinical training in psychiatric pharmacotherapy and mental health outcomes. This successful program offers either a M.S. or Ph.D. degree combined with an ASHP accredited residency in psychiatric pharmacotherapy. The successful individual develops clinical competence in psychiatric pharmacy while developing research expertise in mental health outcomes. Graduate coursework is taken in research methodology, clinical psychopharmacology, clinical psychology, statistics and data analysis, and other areas necessary to enhance the individual's research capabilities. A thesis or dissertation is required for successful completion of the degree program. Additional information about advanced education and training programs in psychiatric pharmacy research and practice can be obtained at: http://www.utexas.edu/pharmacy/divisions/pharmaco/postdoc/index.html

Dr. Crismon has served as a member of the Board of Regents for the American College of Clinical Pharmacy, and he is an ACCP fellow. He served as chairman of the ASHP Specialty Practice Group on Psychopharmacy, chaired the task force to recognize psychiatric pharmacy as a specialty by the Board of Pharmaceutical Specialties (BPS), and was the first chair of the BPS Specialty Council on Psychiatric Pharmacy Practice. He is a past member of the executive committee for the clinical sciences section of the APhA Academy of Pharmaceutical Research and Science. He is a past president, past treasurer, and board member of the Texas Society of Health-System Pharmacists. He was a 1994 co-recipient of the National Head Injury Foundation Distinguished Research Award. He is a recipient of the Robert G. Leonard Memorial Lecture Award, the Philip C. and Ethyl F. Ashby Endowed Lecture Award, and the Judith K. Saklad Lecture Award.

If you wish to contact Dr. Crismon regarding his research or regarding graduate or post-graduate education under his supervision, please phone 512-232-2630 (UT) or 512-206-5068 (TDSHS).

More information about Dr. Crismon
> Publications
> Education & Board Certifications